leisure time -WSS

leisure time

author：focus 2025-08-24 23:09:49 - browse：65886

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug faltered in addressing patient symptoms, causing the company’s stock to fall in early Tuesday trading.

In the Phase 3 trial, the German company was testing its drug candidate pelabresib combined with the drug Jakafi against a Jakafi-placebo duo in patients with newly diagnosed myelofibrosis, a type of rare blood cancer. Jakafi is a standard myelofibrosis treatment.

The drug combination succeeded on its primary endpoint, with 66% of patients seeing at least a 35% reduction in spleen volume after 24 weeks versus 35% on the placebo regimen — an improvement the company in a release called “statistically significant and clinically meaningful.” Myelofibrosis is a rare bone marrow cancer that causes low blood cell counts and enlarged spleens, so reducing spleen volume is commonly used as the primary efficacy goal in clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Prosecutors say FTX founder Sam Bankman

hotspot

entertainment

WSS

The biotech scorecard for the 2nd quarter: 12 industry events to watch

It's time to take a new tack for treating Alzheimer's

As billionaires fund anti

Can gargling with Listerine treat gonorrhea of the mouth?

Trump Organization, Michael Cohen agree to settle million

Pfizer's RSV vaccine recommended for approval in Europe

entertainment

leisure time

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

The cancer drug shortage isn’t new — and neither are the solutions

Most antidepressants don't work on kids, teens, study finds

Hepatitis C has a cure — but many Americans still lack access to it

Florida babysitter arrested over hot car death, authorities say

ChatGPT in medicine: STAT answers readers' burning questions

PBM executives asked to testify by House panel

Activists slam private health insurers over coverage restrictions

Is it ever OK for doctors to lie to their patients?

hotspot

New chart reveals military’s vast involvement in Operation Warp Speed

Why Marc Tessier

How a small hospital in rural Puerto Rico survived Hurricane Maria

AltruBio raises $225 million to develop ulcerative colitis drug

Black vets could get higher VA benefits if race not used in lung test

Brain technologies pose threats that are all too real, experts warn

focus

hotspot

entertainment

entertainment